A group of scientists from the University of the Philippines (UP) Diliman has identified potential biomarkers for lung cancer ...

Small-cell lung cancer (SCLC) is one of the most aggressive and deadly types of cancer, often linked to smoking. Although it ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Li Qiang, director of the respiratory and critical care medicine department at the hospital, said the patient had over 10 ...

Lung Cancer Remains At Bay Long After Immune Therapy Is Dropped By Dennis Thompson HealthDay Reporter MONDAY, April 21, 2025 ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Overall, the one-time LDCT diagnostic performance in the non-risk-based screening population had a sensitivity of 96.6%, a ...

Diliman has identified potential biomarkers or signs that can help with early lung cancer detection with the support of the ...

Previous estimates had put this risk closer to ... Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment Apr. 9, 2025 — Researchers have discovered that 'DEAD ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Turkish scientists have developed an artificial intelligence-supported application designed to detect lung cancer at an early ...

RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...